What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

Panel Discussion | Latest Regulations and Advancements in 503B Production

Panel Discussion | Latest Regulations and Advancements in 503B Production

At FSS, we know that advancing patient safety and regulatory excellence means staying at the forefront of industry dialogue.

We’re excited to share that Deborah (Larkin) McHugh, Vice President of Quality – North America at Fagron, will be speaking at the ISPE 2026 Aseptic Conference.

She will join industry and regulatory leaders in a panel discussion focused on the latest regulations and advancements in 503B production, highlighting how facilities can continue to evolve to meet growing demand while navigating an increasingly complex regulatory landscape.

See the full speaker lineup and event details >

Fagron Sterile Services

Fagron Sterile Services News & Announcements

Fagron North America is a group of innovative, pharmaceutical facilities that focus on optimizing and innovating pharmaceutical compounding. Fagron North America is fully integrated with facilities specializing in 503A Compounding, 503B Human Drug Outsourcing, and providing pharmacists with raw ingredients, supplies, education, and technical support.

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes

Request information from Panel Discussion | Latest Regulations and Advancements in 503B Production

Name
Address
Subscribe